Camden National Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Sell |
1,225
-27
| -2% | -$27.4K | 0.15% | 77 |
|
|
2025
Q4 | $1.35M | Buy |
1,252
+5
| +0.4% | +$4.78K | 0.19% | 72 |
|
|
2025
Q3 | $951K | Sell |
1,247
-16
| -1% | -$11.9K | 0.13% | 77 |
|
|
2025
Q2 | $985K | Sell |
1,263
-7
| -0.6% | -$5.44K | 0.14% | 77 |
|
|
2025
Q1 | $1.05M | Sell |
1,270
-146
| -10% | -$121K | 0.16% | 77 |
|
|
2024
Q4 | $1.09M | Sell |
1,416
-171
| -11% | -$142K | 0.16% | 77 |
|
|
2024
Q3 | $1.41M | Sell |
1,587
-58
| -4% | -$52.1K | 0.2% | 72 |
|
|
2024
Q2 | $1.49M | Buy |
1,645
+7
| +0.4% | +$5.6K | 0.23% | 72 |
|
|
2024
Q1 | $1.27M | Sell |
1,638
-80
| -5% | -$56.9K | 0.22% | 72 |
|
|
2023
Q4 | $1M | Sell |
1,718
-41
| -2% | -$23.9K | 0.19% | 71 |
|
|
2023
Q3 | $945K | Sell |
1,759
-60
| -3% | -$30.9K | 0.19% | 73 |
|
|
2023
Q2 | $853K | Sell |
1,819
-35
| -2% | -$14.7K | 0.17% | 73 |
|
|
2023
Q1 | $637K | Sell |
1,854
-21
| -1% | -$7.08K | 0.13% | 80 |
|
|
2022
Q4 | $686K | Sell |
1,875
-44
| -2% | -$15.6K | 0.14% | 75 |
|
|
2022
Q3 | $621K | Hold |
1,919
| – | – | 0.14% | 79 |
|
|
2022
Q2 | $622K | Hold |
1,919
| – | – | 0.13% | 83 |
|
|
2022
Q1 | $550K | Sell |
1,919
-1,366
| -42% | -$352K | 0.1% | 91 |
|
|
2021
Q4 | $907K | Buy |
3,285
+16
| +0.5% | +$4.06K | 0.16% | 78 |
|
|
2021
Q3 | $755K | Sell |
3,269
-1,082
| -25% | -$267K | 0.15% | 76 |
|
|
2021
Q2 | $999K | Sell |
4,351
-218
| -5% | -$43.8K | 0.19% | 73 |
|
|
2021
Q1 | $853K | Sell |
4,569
-84
| -2% | -$16.4K | 0.17% | 74 |
|
|
2020
Q4 | $786K | Sell |
4,653
-750
| -14% | -$112K | 0.16% | 71 |
|
|
2020
Q3 | $800K | Sell |
5,403
-115
| -2% | -$17.8K | 0.18% | 68 |
|
|
2020
Q2 | $906K | Sell |
5,518
-5
| -0.1% | -$767 | 0.22% | 64 |
|
|
2020
Q1 | $766K | Buy |
5,523
+80
| +1% | +$11K | 0.21% | 64 |
|
|
2019
Q4 | $716K | Buy |
5,443
+856
| +19% | +$99.2K | 0.14% | 73 |
|
|
2019
Q3 | $513K | Sell |
4,587
-651
| -12% | -$72.5K | 0.11% | 77 |
|
|
2019
Q2 | $580K | Buy |
5,238
+234
| +5% | +$27.6K | 0.13% | 73 |
|
|
2019
Q1 | $649K | Sell |
5,004
-25
| -0.5% | -$3.04K | 0.16% | 60 |
|
|
2018
Q4 | $581K | Buy |
5,029
+427
| +9% | +$47.7K | 0.16% | 58 |
|
|
2018
Q3 | $494K | Sell |
4,602
-5
| -0.1% | -$500 | 0.12% | 65 |
|
|
2018
Q2 | $393K | Buy |
4,607
+142
| +3% | +$11.7K | 0.1% | 72 |
|
|
2018
Q1 | $345K | Hold |
4,465
| – | – | 0.1% | 69 |
|
|
2017
Q4 | $377K | Hold |
4,465
| – | – | 0.11% | 60 |
|
|
2017
Q3 | $382K | Hold |
4,465
| – | – | 0.11% | 60 |
|
|
2017
Q2 | $368K | Sell |
4,465
-25
| -0.6% | -$2.04K | 0.11% | 59 |
|
|
2017
Q1 | $378K | Hold |
4,490
| – | – | 0.12% | 59 |
|
|
2016
Q4 | $330K | Buy |
+4,490
| New | +$334K | 0.1% | 66 |
|
Other funds holding LLY
VCM
VPM
Camden National Bank's LLY Position: Q1 2026 in Review
Camden National Bank reduced its Eli Lilly (LLY) stake by 2.2% in Q1 2026, selling an estimated $27.4K and leaving 1,225 shares worth $1.13M. The position accounts for 0.15% of the portfolio, ranked #77.
Camden National Bank first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.49M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Camden National Bank held 1,225 shares of Eli Lilly worth $1.13M as of Q1 2026.
- Camden National Bank sold 27 Eli Lilly shares in Q1 2026, an estimated $27.4K.
- Eli Lilly made up 0.15% of Camden National Bank's portfolio in Q1 2026, its #77 holding.
- Camden National Bank first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- Camden National Bank's Eli Lilly position peaked at $1.49M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Camden National Bank's 13F filing for Q1 2026, filed 4 May 2026.